NIH-R01 (2023-2028): R01 supported by NIAID for the study investigating the role of peritoneal macrophage in Spontaneous Bacterial Peritonitis, a devastating complication of end-stage liver disease. (PI: Saito)
NIH-R21 (2018-2021): R21 supported by NIAID for the study of occult HCV infection (OCI).
NIH-R01 (2015-2021): R01 supported by NIDDK for the study of a novel anti-viral kinase, TNK1.
NIH-R21 (2014-2021): R21 supported by NIAAA investigating the role of micronutrients in the synergistic pathogenesis of HCV infection and alcoholic liver disease.
PhoenixBio (2018-2028): Research funding from PhoenixBio for the study of Humanized Liver Chimeric Mouse Model.
